Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership to support Crinetics’ CRN04894 pediatric program. The partnership will utilize Quotient Sciences’ unique Translational Pharmaceutics® platform to
External URL: https://www.quotientsciences.com/news/crinetics-pharmaceuticals-pediatric-development-program/
By Arcinova
495 Views
Recent Posts
- January 31st Deadline: Important Customs Update regarding Entry Summary Declarations for Safety and Security.
- AESSEAL receives two new Robotic Cells, as part of £7.5 Million Investment in technology
- Machinery Electrical Control Panel Common Errors
- Waterstons Manufacturing Network Breakfast
- Kieron Watson: From Site Contracts Engineer to Site Contracts Manager
Back to News >
Share this
Most Recent Post
January 31st Deadline: Important Customs Update regarding Entry Summary Declarations for Safety and Security.
23 Dec 2024
Read more >
© Copyright. North East of England Process Industry Cluster (NEPIC) 2015
Built by iTCHYROBOT